Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Dec 1;98(11):2496–2506. doi: 10.1172/JCI119068

Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection.

T E Caver 1, F X O'Sullivan 1, L I Gold 1, H D Gresham 1
PMCID: PMC507707  PMID: 8958212

Abstract

Infection remains a leading cause of morbidity and mortality in patients with SLE. To investigate this, previously we assessed the host defense status of autoimmune MRL/lpr mice and found that elaboration of active TGFbeta suppressed neutrophil function and decreased survival in response to Staphylococcus aureus infection. The purpose of the present work was to elucidate the molecular form and the cellular source of the active TGFbeta involved. Here, we report for the first time that TGFbeta1 is found in the active form inside B cells and plasma cells and that it circulates in the plasma complexed with IgG in two murine models of systemic autoimmunity and in some patients with SLE. IgG-bound active TGFbeta1 is many times more potent than uncomplexed active TGFbeta1 for suppression of neutrophil function in vitro and host defense against S. aureus infection in vivo. These data indicate that TGFbeta1 is in the active form inside B cells and plasma cells, that the formation of a complex of IgG and active TGFbeta1 is greatly accelerated in autoimmunity, and that this complex is extremely potent for suppression of PMN function and host defense against bacterial infection.

Full Text

The Full Text of this article is available as a PDF (377.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Shakra M., Urowitz M. B., Gladman D. D., Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995 Jul;22(7):1259–1264. [PubMed] [Google Scholar]
  2. Allen J. B., Manthey C. L., Hand A. R., Ohura K., Ellingsworth L., Wahl S. M. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med. 1990 Jan 1;171(1):231–247. doi: 10.1084/jem.171.1.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allen J. B., Wong H. L., Guyre P. M., Simon G. L., Wahl S. M. Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest. 1991 May;87(5):1773–1779. doi: 10.1172/JCI115196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Border W. A., Okuda S., Languino L. R., Sporn M. B., Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 1990 Jul 26;346(6282):371–374. doi: 10.1038/346371a0. [DOI] [PubMed] [Google Scholar]
  5. Bouchard C., Galinha A., Tartour E., Fridman W. H., Sautès C. A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor. J Exp Med. 1995 Dec 1;182(6):1717–1726. doi: 10.1084/jem.182.6.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brandes M. E., Allen J. B., Ogawa Y., Wahl S. M. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest. 1991 Mar;87(3):1108–1113. doi: 10.1172/JCI115073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brandes M. E., Mai U. E., Ohura K., Wahl S. M. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol. 1991 Sep 1;147(5):1600–1606. [PubMed] [Google Scholar]
  8. Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994 Aug 26;265(5176):1237–1240. doi: 10.1126/science.7520605. [DOI] [PubMed] [Google Scholar]
  9. Dale D. C., Petersdorf R. G. Corticosteroids and infectious diseases. Med Clin North Am. 1973 Sep;57(5):1277–1287. doi: 10.1016/s0025-7125(16)32228-3. [DOI] [PubMed] [Google Scholar]
  10. Dang H., Geiser A. G., Letterio J. J., Nakabayashi T., Kong L., Fernandes G., Talal N. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol. 1995 Sep 15;155(6):3205–3212. [PubMed] [Google Scholar]
  11. Danielpour D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J Immunol Methods. 1993 Jan 14;158(1):17–25. doi: 10.1016/0022-1759(93)90254-5. [DOI] [PubMed] [Google Scholar]
  12. Dasch J. R., Pace D. R., Waegell W., Inenaga D., Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol. 1989 Mar 1;142(5):1536–1541. [PubMed] [Google Scholar]
  13. Duffy K. N., Duffy C. M., Gladman D. D. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol. 1991 Aug;18(8):1180–1184. [PubMed] [Google Scholar]
  14. Ellis M., Gupta S., Galant S., Hakim S., VandeVen C., Toy C., Cairo M. S. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis. 1988 Dec;158(6):1268–1276. doi: 10.1093/infdis/158.6.1268. [DOI] [PubMed] [Google Scholar]
  15. Goddard D. H., Kirk A. P., Kirwan J. R., Johnson G. D., Holborow E. J. Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis. Ann Rheum Dis. 1984 Apr;43(2):151–156. doi: 10.1136/ard.43.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gresham H. D., Ray C. J., O'Sullivan F. X. Defective neutrophil function in the autoimmune mouse strain MRL/lpr. Potential role of transforming growth factor-beta. J Immunol. 1991 Jun 1;146(11):3911–3921. [PubMed] [Google Scholar]
  17. Huang F. P., Feng G. J., Lindop G., Stott D. I., Liew F. Y. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med. 1996 Apr 1;183(4):1447–1459. doi: 10.1084/jem.183.4.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kuruvilla A. P., Shah R., Hochwald G. M., Liggitt H. D., Palladino M. A., Thorbecke G. J. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918–2921. doi: 10.1073/pnas.88.7.2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lim S. H., Giles F. J., Smith M. P., Goldstone A. H. Bacterial infections in lymphoma patients treated with recombinant interleukin-2. Acta Haematol. 1991;85(3):135–138. doi: 10.1159/000204875. [DOI] [PubMed] [Google Scholar]
  20. Lotz M., Seth P. TGF beta and HIV infection. Ann N Y Acad Sci. 1993 Jun 23;685:501–511. doi: 10.1111/j.1749-6632.1993.tb35912.x. [DOI] [PubMed] [Google Scholar]
  21. Lowrance J. H., O'Sullivan F. X., Caver T. E., Waegell W., Gresham H. D. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J Exp Med. 1994 Nov 1;180(5):1693–1703. doi: 10.1084/jem.180.5.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nived O., Sturfelt G., Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med. 1985 Jun;55(218):271–287. [PubMed] [Google Scholar]
  23. Nunes I., Shapiro R. L., Rifkin D. B. Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol. 1995 Aug 1;155(3):1450–1459. [PubMed] [Google Scholar]
  24. Parekh T., Saxena B., Reibman J., Cronstein B. N., Gold L. I. Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin. J Immunol. 1994 Mar 1;152(5):2456–2466. [PubMed] [Google Scholar]
  25. Pelton R. W., Saxena B., Jones M., Moses H. L., Gold L. I. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991 Nov;115(4):1091–1105. doi: 10.1083/jcb.115.4.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pistiner M., Wallace D. J., Nessim S., Metzger A. L., Klinenberg J. R. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991 Aug;21(1):55–64. doi: 10.1016/0049-0172(91)90057-7. [DOI] [PubMed] [Google Scholar]
  27. Puolakkainen P., Twardzik D., Ranchalis J., Moroni M., Mandeli J., Paciucci P. A. Increase of plasma transforming growth factor beta (TGF beta) during immunotherapy with IL-2. Cancer Invest. 1995;13(6):583–589. doi: 10.3109/07357909509024926. [DOI] [PubMed] [Google Scholar]
  28. Reveille J. D., Bartolucci A., Alarcón G. S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990 Jan;33(1):37–48. doi: 10.1002/art.1780330105. [DOI] [PubMed] [Google Scholar]
  29. Rosner S., Ginzler E. M., Diamond H. S., Weiner M., Schlesinger M., Fries J. F., Wasner C., Medsger T. A., Jr, Ziegler G., Klippel J. H. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 1982 Jun;25(6):612–617. doi: 10.1002/art.1780250602. [DOI] [PubMed] [Google Scholar]
  30. Rowley D. A., Becken E. T., Stach R. M. Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses. J Exp Med. 1995 May 1;181(5):1875–1880. doi: 10.1084/jem.181.5.1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sanderson N., Factor V., Nagy P., Kopp J., Kondaiah P., Wakefield L., Roberts A. B., Sporn M. B., Thorgeirsson S. S. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2572–2576. doi: 10.1073/pnas.92.7.2572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Satoh M., Kumar A., Kanwar Y. S., Reeves W. H. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10934–10938. doi: 10.1073/pnas.92.24.10934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schultz-Cherry S., Ribeiro S., Gentry L., Murphy-Ullrich J. E. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem. 1994 Oct 28;269(43):26775–26782. [PubMed] [Google Scholar]
  34. Snydman D. R., Sullivan B., Gill M., Gould J. A., Parkinson D. R., Atkins M. B. Nosocomial sepsis associated with interleukin-2. Ann Intern Med. 1990 Jan 15;112(2):102–107. doi: 10.7326/0003-4819-112-2-102. [DOI] [PubMed] [Google Scholar]
  35. Stach R. M., Rowley D. A. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med. 1993 Sep 1;178(3):841–852. doi: 10.1084/jem.178.3.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Staples P. J., Gerding D. N., Decker J. L., Gordon R. S., Jr Incidence of infection in systemic lupus erythematosus. Arthritis Rheum. 1974 Jan-Feb;17(1):1–10. doi: 10.1002/art.1780170102. [DOI] [PubMed] [Google Scholar]
  37. Wahl S. M. Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med. 1994 Nov 1;180(5):1587–1590. doi: 10.1084/jem.180.5.1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wandall J. H. Leucocyte function in patients with rheumatoid arthritis: quantitative in-vivo leucocyte mobilisation and in-vitro functions of blood and exudate leucocytes. Ann Rheum Dis. 1985 Oct;44(10):694–700. doi: 10.1136/ard.44.10.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wheat L. J. Infection and diabetes mellitus. Diabetes Care. 1980 Jan-Feb;3(1):187–197. doi: 10.2337/diacare.3.1.187. [DOI] [PubMed] [Google Scholar]
  40. Wilson R. M., Reeves W. G. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol. 1986 Feb;63(2):478–484. [PMC free article] [PubMed] [Google Scholar]
  41. Witt D. J., Craven D. E., McCabe W. R. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med. 1987 May;82(5):900–906. doi: 10.1016/0002-9343(87)90150-1. [DOI] [PubMed] [Google Scholar]
  42. Yaswen L., Kulkarni A. B., Fredrickson T., Mittleman B., Schiffman R., Payne S., Longenecker G., Mozes E., Karlsson S. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood. 1996 Feb 15;87(4):1439–1445. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES